# Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder

> **NCT00325286** · PHASE4 · UNKNOWN · sponsor: **Creighton University** · enrollment: 20 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium Plus Extended- Release Carbamazepine

## Key facts

- **NCT ID:** NCT00325286
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2007-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325286, "Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00325286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*